Page last updated: 2024-11-07

estrone and Genetic Predisposition

estrone has been researched along with Genetic Predisposition in 14 studies

Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.

Research Excerpts

ExcerptRelevanceReference
"It has been hypothesized that the ratio of urinary 2-hydroxyestrone to 16alpha-hydroxyestrone (2-OHE1/16alpha-OHE1 represents a biomarker for breast cancer risk; the lower the ratio the higher the risk."7.71Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women. ( Bernstein, L; Gentzschein, E; London, S; Pike, MC; Stanczyk, FZ; Tseng, CC; Ursin, G; Yang, D, 2002)
"E1Cs have been associated with breast cancer risk and may contribute to tumor progression since STS is expressed in breast cancer where its activity exceeds that of aromatase."5.46SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway. ( Barman, P; Batzler, A; Buzdar, AU; Carlson, EE; Dudenkov, TM; Goetz, MP; Ibrahim-Zada, I; Ingle, JN; Jenkins, GD; Kalari, KR; Kubo, M; Moreno-Aspita, A; Nakamura, Y; Northfelt, DW; Pietrzak, TL; Robson, ME; Wang, L; Weinshilboum, RM; Williard, CV, 2017)
"Estrone sulfate was statistically significantly associated with breast cancer risk among women with low (< 1."3.73Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? ( Eliassen, AH; Hankinson, SE; Missmer, SA; Tworoger, SS, 2006)
"It has been hypothesized that the ratio of urinary 2-hydroxyestrone to 16alpha-hydroxyestrone (2-OHE1/16alpha-OHE1 represents a biomarker for breast cancer risk; the lower the ratio the higher the risk."3.71Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women. ( Bernstein, L; Gentzschein, E; London, S; Pike, MC; Stanczyk, FZ; Tseng, CC; Ursin, G; Yang, D, 2002)
"Women at elevated risk for breast cancer are motivated to reduce their risk."2.80Women In Steady Exercise Research (WISER) Sister: study design and methods. ( Adelman, J; Bryan, CJ; DiGiovanni, L; Domchek, S; Fenderson, D; Galantino, ML; Good, J; Grant, L; Hwang, WT; Kontos, D; Kurzer, MS; Morales, K; Salvatore, D; Schmitz, KH; Schnall, M; Stopfer, J; Sturgeon, K; Williams, NI; Wu, S, 2015)
"E1Cs have been associated with breast cancer risk and may contribute to tumor progression since STS is expressed in breast cancer where its activity exceeds that of aromatase."1.46SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway. ( Barman, P; Batzler, A; Buzdar, AU; Carlson, EE; Dudenkov, TM; Goetz, MP; Ibrahim-Zada, I; Ingle, JN; Jenkins, GD; Kalari, KR; Kubo, M; Moreno-Aspita, A; Nakamura, Y; Northfelt, DW; Pietrzak, TL; Robson, ME; Wang, L; Weinshilboum, RM; Williard, CV, 2017)
"Spontaneous pneumothorax is mostly sporadic but may also occur in families with genetic disorders, such as Birt-Hogg-Dubé syndrome, which is caused by mutations in the folliculin (FLCN) gene."1.35Novel mutations in the folliculin gene associated with spontaneous pneumothorax. ( Alkadhi, H; Berger, W; Fröhlich, BA; Mátyás, G; Russi, EW; Tuor, C; Zeitz, C, 2008)
"Associations of genotypes with breast cancer risk were evaluated in the case-control study and with hormone levels in the postmenopausal women using multiple linear regression with assay batch, body mass index, parity, peri- or postmenopausal status, and age band as covariates."1.32Polymorphisms associated with circulating sex hormone levels in postmenopausal women. ( Day, NE; Dowsett, M; Dunning, AM; Easton, DF; Folkerd, E; Healey, CS; Kelemen, L; Luben, RN; Novik, KL; Ogata, S; Pharoah, PD; Ponder, BA; Tee, L, 2004)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (57.14)29.6817
2010's5 (35.71)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Ruan, X1
Seeger, H1
Wallwiener, D1
Huober, J1
Mueck, AO1
Ursin, G1
London, S1
Yang, D1
Tseng, CC1
Pike, MC1
Bernstein, L2
Stanczyk, FZ2
Gentzschein, E1
Ingle, JN2
Kalari, KR2
Barman, P2
Shepherd, LE1
Ellis, MJ1
Goss, PE1
Buzdar, AU2
Robson, ME2
Cairns, J1
Carlson, EE2
Eyman Casey, A1
Hoskin, TL1
Goodnature, BA1
Haddad, TC1
Goetz, MP2
Weinshilboum, RM2
Wang, L2
Dudenkov, TM1
Kubo, M1
Ibrahim-Zada, I1
Batzler, A1
Jenkins, GD1
Pietrzak, TL1
Northfelt, DW1
Moreno-Aspita, A1
Williard, CV1
Nakamura, Y1
Schmitz, KH1
Williams, NI1
Kontos, D1
Kurzer, MS1
Schnall, M1
Domchek, S1
Stopfer, J1
Galantino, ML1
Hwang, WT1
Morales, K1
Wu, S1
DiGiovanni, L1
Salvatore, D1
Fenderson, D1
Good, J1
Sturgeon, K1
Grant, L1
Bryan, CJ1
Adelman, J1
Fröhlich, BA1
Zeitz, C1
Mátyás, G1
Alkadhi, H1
Tuor, C1
Berger, W1
Russi, EW1
Terry, K1
McGrath, M1
Lee, IM1
Buring, J1
De Vivo, I1
Johnson, N1
Walker, K1
Gibson, LJ1
Orr, N1
Folkerd, E2
Haynes, B1
Palles, C1
Coupland, B1
Schoemaker, M1
Jones, M1
Broderick, P1
Sawyer, E1
Kerin, M1
Tomlinson, IP1
Zvelebil, M1
Chilcott-Burns, S1
Tomczyk, K1
Simpson, G1
Williamson, J1
Hillier, SG1
Ross, G1
Houlston, RS1
Swerdlow, A1
Ashworth, A1
Dowsett, M2
Peto, J1
Dos Santos Silva, I1
Fletcher, O1
Nickerson, ML1
Warren, MB1
Toro, JR1
Matrosova, V1
Glenn, G1
Turner, ML1
Duray, P1
Merino, M1
Choyke, P1
Pavlovich, CP1
Sharma, N1
Walther, M1
Munroe, D1
Hill, R1
Maher, E1
Greenberg, C1
Lerman, MI1
Linehan, WM1
Zbar, B1
Schmidt, LS1
Dunning, AM1
Healey, CS1
Tee, L1
Luben, RN1
Novik, KL1
Kelemen, L1
Ogata, S1
Pharoah, PD1
Easton, DF1
Day, NE1
Ponder, BA1
Dereure, O1
Eliassen, AH1
Missmer, SA1
Tworoger, SS1
Hankinson, SE1
Fan, J1
McKean-Cowdin, R1
Li, AX1
Ballard-Barbash, R1
McTiernan, A1
Baumgartner, R1
Gilliland, F1
Kim, EH1
Jeong, SY1
Kim, HJ1
Kim, YC1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prevalence of Birt-Hogg-Dubé Syndrome Among Patients With (Hereditary) Spontaneous Pneumothorax[NCT02916992]Phase 1200 participants (Anticipated)Interventional2016-09-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for estrone and Genetic Predisposition

ArticleYear
Women In Steady Exercise Research (WISER) Sister: study design and methods.
    Contemporary clinical trials, 2015, Volume: 41

    Topics: Adiponectin; Adult; Breast; Breast Neoplasms; Estrone; Exercise Therapy; Female; Genes, BRCA1; Genes

2015
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
    Journal of the National Cancer Institute, 2012, May-02, Volume: 104, Issue:9

    Topics: Adult; Age Factors; Androgens; Breast Neoplasms; Case-Control Studies; Cross-Sectional Studies; Cyto

2012

Other Studies

12 other studies available for estrone and Genetic Predisposition

ArticleYear
The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.
    Archives of gynecology and obstetrics, 2015, Volume: 291, Issue:5

    Topics: Adult; Biomarkers; Breast Neoplasms; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Estrad

2015
Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
    Breast cancer research and treatment, 2002, Volume: 72, Issue:2

    Topics: Adult; Biomarkers; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Genetic Predisp

2002
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
    Pharmacogenetics and genomics, 2021, Volume: 31, Issue:1

    Topics: Adult; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Female; Genetic Pred

2021
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.
    Breast cancer research and treatment, 2017, Volume: 164, Issue:1

    Topics: Adult; Aged; Breast Neoplasms; Estrone; Female; Genetic Predisposition to Disease; Genome-Wide Assoc

2017
Novel mutations in the folliculin gene associated with spontaneous pneumothorax.
    The European respiratory journal, 2008, Volume: 32, Issue:5

    Topics: Adult; DNA Mutational Analysis; Estrone; Exons; Family Health; Female; Genetic Predisposition to Dis

2008
Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.
    Gynecologic oncology, 2010, Volume: 117, Issue:2

    Topics: Adult; Alleles; Case-Control Studies; Cholesterol Side-Chain Cleavage Enzyme; Endometrial Neoplasms;

2010
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.
    Cancer cell, 2002, Volume: 2, Issue:2

    Topics: Amino Acid Sequence; Base Sequence; Chromosomes, Human, Pair 17; Conserved Sequence; DNA Mutational

2002
Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
    Journal of the National Cancer Institute, 2004, Jun-16, Volume: 96, Issue:12

    Topics: 17-alpha-Hydroxyprogesterone; Aged; Androstenedione; Aromatase; Aryl Hydrocarbon Hydroxylases; Breas

2004
[Mutations of tumor suppressor genes coding for folliculin in Birt Hogg Dube syndrome].
    Annales de dermatologie et de venereologie, 2005, Volume: 132, Issue:1

    Topics: Estrone; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Humans; Mutation; Skin Diseases

2005
Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Apr-20, Volume: 24, Issue:12

    Topics: Adult; Breast Neoplasms; Case-Control Studies; Estradiol; Estrone; Female; Genetic Predisposition to

2006
An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivors.
    Breast cancer research and treatment, 2006, Volume: 99, Issue:3

    Topics: Black or African American; Breast Neoplasms; C-Reactive Protein; Cohort Studies; Estradiol; Estrone;

2006
A case of Birt-Hogg-Dubé syndrome.
    Journal of Korean medical science, 2008, Volume: 23, Issue:2

    Topics: Adult; Biopsy; Diagnosis, Differential; DNA Mutational Analysis; Estrone; Exons; Female; Gene Deleti

2008